CSBR vs TGT · P/E 16, rev $59.4M vs P/E 17, rev $51.98B
Champions Oncology Inc (CSBR) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Brian Cornell.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the CSBR and TGT stock pages for the full models.
Not investment advice.